|
|
|
|
|
|
|
|
|
|
|
28.05.25 - 14:39
|
AdvoCare® Welcomes Brad Pace as Vice President of Regulatory Affairs & Compliance (Business Wire)
|
|
|
Brad's Expertise Matches Our Commitment to Product ComplianceRICHARDSON, Texas--(BUSINESS WIRE)--#AdvoCareRehydrate--AdvoCare International, LLC, a health and wellness e-commerce company, is delighted to welcome Brad Pace to the AdvoCare team as Vice President of Regulatory Affairs & Compliance. Brad has built his career in the field of regulatory affairs, bringing his dedication and expertise to AdvoCare.
“Brad's in-depth knowledge in the regulatory affairs and compliance space made him the perfect leader for this segment of our business,” said Christina Helwig, CEO of AdvoCare. “On behalf of our entire team, I'd like to welcome Brad to AdvoCare formally!”
After co-founding and growing a successful regional CPG company with his family—where he discovered a talent for bridging the legal and product worlds—Brad went on to join USANA Health Sciences, Inc., a global leader in health and wellness. He began as a Regulatory Specialist and advanced to become Executive Director of Regulatory Affair...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22.04.25 - 22:06
|
USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook (Business Wire)
|
|
|
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended March 29, 2025.
Key Financial Results
First Quarter 2025 vs. First Quarter 2024
Net sales of $250 million versus $228 million, representing year-over-year growth of 10% and 12% in constant currency.
Net earnings of $9.4 million versus $16.5 million.
Diluted EPS of $0.49 as compared with $0.86.
Adjusted diluted EPS(1) of $0.73 as compared with $0.86.
Adjusted EBITDA(2) of $30 million versus $33 million.
Direct selling Active Customers of 459,000 versus 494,000.
Hiya Active Monthly Subscribers of 224,000.
Company reiterates fiscal year 2025 outlook.
Q1 2025 Financial Performance
Consolidated Results
Year-over-Year
Sequentially
Net Sales
$250 million
+10% (-$6 million or -2% FX impact)
+17%
Net Earnings
$9.4 million
-43%
+111%
Diluted EPS
$0.49
-43%
+113%
Adjusted Diluted EPS(1)
$0.73
-15%
+15%
Adjusted EBITDA(2)
$30 million
-10%
+17%
Net earnings, EPS and EBITDA f...
|
|
|
|
|
08.04.25 - 22:09
|
USANA Schedules First Quarter 2025 Earnings Release and Conference Call (Business Wire)
|
|
|
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2025 results will be released after the close of market on Tuesday, April 22, 2025. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, April 23, 2025 at 11:00 a.m. Eastern Time.
The call will be broadcast over the Internet and can be accessed at http://ir.usana.com.
About USANA
USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philipp...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
